Medicare Enrolled

Dr. Olga Waln, M.D.

Neurology · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
6560 FANNIN ST, Houston, TX 77030
7134419551
In practice since 2007 (18 years)
NPI: 1013133768 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Waln from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Waln? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Waln

Dr. Olga Waln is a neurology in Houston, TX, with 18 years in practice. Based on federal Medicare data, Dr. Waln performed 29,605 Medicare services across 582 unique beneficiaries.

Between the years covered by Open Payments, Dr. Waln received a total of $30,931 from 64 pharmaceutical and/or device companies across 731 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Waln is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 3% volume in TX$ $30,931 industry payments

Medicare Practice Summary

Medicare Utilization ↗
29,605
Medicare services
Top 3% in TX for neurology
582
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,645 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit28,500$5$8
Office visit, established patient (30-39 min)536$89$236
Office visit, established patient (20-29 min)138$72$159
Office visit, established patient, complex (40-54 min)78$124$316
Hospital follow-up visit, moderate complexity52$64$150
Injection of chemical for paralysis of nerve muscles on side of face51$151$450
Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box46$137$440
New patient office visit, complex (60-74 min)43$164$450
Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional36$37$266
Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity35$74$300
Initial hospital admission, moderate complexity35$102$270
Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity29$100$300
Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator26$15$300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$30,931
Total received (2018-2024)
Avg $4,419/year across 7 years
Top 13% in TX for neurology
64
Companies
731
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,770 (44.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,853 (35.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,308 (20.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,538
2023
$2,997
2022
$5,373
2021
$2,317
2020
$2,243
2019
$12,414
2018
$3,050

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$8,038
Amneal Pharmaceuticals LLC
$6,269
ACADIA Pharmaceuticals Inc
$2,800
Acorda Therapeutics, Inc
$2,503
JAZZ PHARMACEUTICALS INC.
$1,567
Teva Pharmaceuticals USA, Inc.
$901
ABBVIE INC.
$861
Medtronic, Inc.
$788
Merz Pharmaceuticals, LLC
$779
Abbott Laboratories
$472
AbbVie Inc.
$446
Lundbeck LLC
$428
Supernus Pharmaceuticals, Inc.
$404
Boston Scientific Corporation
$330
CSL Behring
$325
Merz North America, Inc.
$296
Avion Pharmaceuticals
$294
Kyowa Kirin, Inc.
$196
Sunovion Pharmaceuticals Inc.
$193
Allergan Inc.
$181
ARBOR PHARMACEUTICALS, INC.
$181
BOSTON SCIENTIFIC CORPORATION
$172
Otsuka America Pharmaceutical, Inc.
$164
Ipsen Biopharmaceuticals, Inc
$155
Medtronic USA, Inc.
$152
Avanir Pharmaceuticals, Inc.
$149
Adamas Pharmaceuticals, Inc.
$133
US WorldMeds, LLC
$126
Azurity Pharmaceuticals, Inc.
$117
Grifols USA, LLC
$114
Biogen, Inc.
$110
MDD US Operations, LLC
$103
Amgen Inc.
$99
GE HEALTHCARE
$78
Allergan, Inc.
$71
Lilly USA, LLC
$69
UCB, Inc.
$65
PFIZER INC.
$65
GENZYME CORPORATION
$65
Arbor Pharmaceuticals, Inc.
$62
Novartis Pharmaceuticals Corporation
$50
SK Life Science, Inc.
$47
Collegium Pharmaceutical, Inc.
$40
Upsher-Smith Laboratories LLC
$40
Biohaven Pharmaceutical Holding Company Ltd.
$37
Impax Laboratories, Inc.
$36
Piramal Critical Care
$32
CATALYST PHARMACEUTICALS, INC.
$32
EMD Serono, Inc.
$29
AbbVie, Inc.
$25
HARMONY BIOSCIENCES LLC
$23
Corium, LLC
$22
Cala Health, Inc.
$21
Harmony Biosciences LLC
$19
IMPEL PHARMACEUTICALS INC.
$19
Genentech, Inc.
$18
Electromed, Inc.
$18
Vertical Pharmaceuticals, LLC
$17
Shire North American Group Inc
$17
InSightec,Inc
$15
SANOFI-AVENTIS U.S. LLC
$14
IDORSIA PHARMACEUTICALS US INC
$13
Merck Sharp & Dohme LLC
$12
Mylan Pharmaceuticals Inc.
$11
Top 3 companies account for 55.3% of total payments
Associated products mentioned in payments ›
ACTIVA · ACTIVA PC · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Apokyn · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Briviact · CALA KIQ · COPAXONE · CREXONT · DAYBUE · DUOPA · DYSPORT · Dhivy · Dysport · ELYXYB - celecoxib · EMGALITY · Edarbi · Edarbyclor · Exablate · FIRDAPSE · GABLOFEN · GAMMAGARD · GENERAL DBS · GENERAL DBS · GENERAL DBS · GOCOVRI · Gamunex-C · General - DBS · Glatiramer Acetate · HORIZANT · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LYRICA · MYOBLOC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · ONGENTYS · OSMOLEX ER · Ongentys · PERCEPT PC BRAINSENSE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · Qelbree · RYTARY · SKYCLARYS · SMARTVEST · SYNCHROMEDII · TROKENDI XR · Trudhesa · UBRELVY · VYALEV · VYEPTI · Vercise · Vimpat · Wakix · XEOMIN · Xadago · Xeomin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (44%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $104 per 100 Medicare services performed
Looking for a neurology in Houston?
Compare neurologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
382
Per 100K population
8.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Waln is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (mixed engagement, top 13%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Waln experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Waln performed 28,500 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Waln receive payments from pharmaceutical companies?
Yes. Dr. Waln received a total of $30,931 from 64 companies across 731 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Waln's costs compare to other neurologys in Houston?
Dr. Waln's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Waln) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →